Oruka Therapeutics (ORKA) Cash from Investing Activities Growth (1y) (2011 - 2026)
Oruka Therapeutics (ORKA) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - | -133.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.68% |
| Dec 31, 2025 | 93.33% |
| Sep 30, 2025 | -71,507.60% |
| Mar 31, 2022 | 66.67% |
| Dec 31, 2021 | 46.15% |
| Jun 30, 2021 | -433.33% |
| Mar 31, 2021 | -100.00% |
| Dec 31, 2020 | -550.00% |
| Sep 30, 2018 | 99.68% |
| Mar 31, 2018 | 1.36% |
| Dec 31, 2017 | 50.86% |
| Sep 30, 2017 | 63.42% |
| Jun 30, 2017 | 151.65% |
| Mar 31, 2017 | 157.82% |
| Dec 31, 2016 | 157,500.00% |
| Sep 30, 2016 | -127,300.00% |
| Jun 30, 2016 | -236,140.00% |
| Mar 31, 2016 | -260,000.00% |
| Dec 31, 2015 | 85.71% |
| Dec 31, 2014 | -250.00% |